Peanut (Ara h 6) IgE

If you have ever wondered whether a positive peanut test really means you would react to peanut, this is the marker that helps answer that question. Ara h 6 IgE measures antibodies aimed at one of the two storage proteins most closely tied to genuine, sometimes severe, peanut reactions.

A standard peanut IgE test detects antibodies to a mixed extract of peanut proteins, which often produces positives in people who can eat peanuts without issue. Ara h 6 zooms in on a single, clinically meaningful target, giving you a much cleaner read on whether your peanut sensitivity is the kind that matters.

What Ara h 6 Actually Is

Ara h 6 is one of the most important allergy-triggering proteins in a peanut, belonging to a small family of seed storage proteins called 2S albumins. It shares about 60% of its protein sequence with its better-known sibling, Ara h 2, and in many people who react to peanut, IgE antibodies bind to both. Almost every highly peanut-allergic person makes IgE against Ara h 2, Ara h 6, or both.

The IgE (immunoglobulin E) antibody itself is made by specialized immune cells (B cells and plasma cells) in lymph nodes, the spleen, and mucosal tissues throughout the body, including those lining the airway and gut. When those antibodies coat mast cells and basophils (the immune cells that release histamine), even a small bite of peanut can trigger the chain reaction that produces hives, swelling, vomiting, or full anaphylaxis.

Why This Marker Matters for True Peanut Allergy

Sensitization is not the same as allergy. Plenty of people have detectable peanut IgE on a routine test but eat peanut butter without trouble. Ara h 6 IgE narrows that gap, because antibodies aimed at this specific storage protein track much more closely with actual reactions on a food challenge.

In UK children, Ara h 6 IgE separated peanut-allergic from peanut-sensitized-but-tolerant kids with an AUC of 0.91 (a measure of how well a test sorts two groups, where 1.0 is perfect and 0.5 is a coin flip). Other studies in adults and Japanese children have reported AUCs in the 0.82 to 0.85 range, though reported values vary widely depending on the population, severity threshold, and challenge protocol used.

Reaction Severity and Threshold

At the population level, Ara h 6 IgE carries information about how badly people tend to react, not only whether they react. In a Finnish double-blind placebo-controlled food challenge study, co-sensitization to Ara h 2 and Ara h 6 was the best predictor of moderate-to-severe peanut allergy, with Ara h 6 standing out as a strong group-level marker for the more dangerous reactors (AUC 0.98 for moderate-to-severe reactions).

At the individual level, the picture is different. In Japanese children, higher Ara h 6 IgE tracked with a higher chance of reacting on a supervised peanut challenge, but the AAAAI practice parameter is explicit that no IgE level, including Ara h 6, reliably predicts who will have full anaphylaxis versus a milder reaction in any one person. The signal is informative across groups but not a forecasting tool for individuals.

When the Standard Peanut Test Misses It

Most clinical labs report a single peanut IgE based on whole peanut extract. That number is sensitive but not specific: lots of people who score positive are actually fine eating peanuts. Component tests like Ara h 6 (and Ara h 2) shift that balance, trading some sensitivity for much higher specificity, so a clear positive is far more meaningful.

There is also a small but real group of people who react to peanut almost entirely through Ara h 6, with little or no IgE to Ara h 2. A case series and several diagnostic studies have documented mono-sensitization to Ara h 6, sometimes with severe reactions. If your workup includes only the standard peanut IgE or only Ara h 2, this pattern can be missed.

How It Compares to Ara h 2

Ara h 2 is generally considered the dominant peanut allergen, and most algorithms lead with it. Across studies, Ara h 6 performs nearly identically: similar AUCs, similar specificity, similar value at high cutoffs. In adult challenge studies, both reached a high positive predictive value at elevated cutoffs, though overall sensitivity was more limited.

The catch is that individual patients sometimes show discordant results, where one component is clearly positive and the other is borderline or negative. Because of this, testing both Ara h 2 and Ara h 6 catches a few more allergic people than testing either one alone, and reduces the risk of misdiagnosis from a single discordant value. It is worth knowing that the 2020 AAAAI practice parameter conditionally recommends against routine component testing beyond Ara h 2 to confirm whole peanut IgE results, so adding Ara h 6 is a reasonable extension of the workup in selected cases rather than a universally guideline-endorsed step.

Tracking Changes Over Time

A single Ara h 6 IgE result is a snapshot of your current immune state. Antibody levels change with age, allergen exposure, and treatment, so the trajectory often matters more than any one number. In children, falling Ara h 2 and Ara h 6 IgE alongside rising peanut-specific IgG4 tend to mark natural resolution or a positive response to therapy. In Australian and Korean cohorts, roughly one in three children with peanut allergy outgrew it by age ten.

If you are starting peanut oral immunotherapy or any structured desensitization, Ara h 6 IgE typically falls while Ara h 6 IgG4 rises, shifting the IgG4-to-IgE ratio in a direction that reflects immune modulation. No formal guideline specifies how often to retest component IgE, but a reasonable expert-opinion cadence is a baseline test, repeat at 3 to 6 months if you are pursuing any intervention or believe your allergy may be resolving, and at least annual monitoring otherwise. The trend is far more informative than any isolated value.

When Results Can Be Misleading

Low-positive Ara h 6 values overlap between people who are truly allergic and people who tolerate peanut. A small value does not cleanly classify you either way, especially without a clear clinical history. Component IgE testing also cannot predict the severity of any individual future reaction, despite the population-level trends linking high values to worse outcomes; the AAAAI practice parameter explicitly cautions against using any antibody test to forecast how bad an individual's next reaction will be.

A small subset of people will have a convincing peanut reaction history despite very low or even undetectable Ara h 6 IgE. In these cases, a basophil activation test (a functional lab test using your live immune cells) or a supervised oral food challenge may be needed to confirm or rule out allergy. Antibody tests measure what your immune system has produced, not necessarily how those antibodies will behave on contact with peanut.

What an Unexpected Result Should Make You Do

A clearly elevated Ara h 6 IgE without a known peanut allergy history is a reason to stop, not to start avoiding peanuts on your own. The next step is a board-certified allergist who can integrate your symptoms, eating history, Ara h 2 result, skin prick test, and, if needed, an in-clinic oral food challenge or basophil activation test. Self-diagnosis from a single antibody number leads to unnecessary food restriction, which has its own real costs.

If you already carry a peanut allergy diagnosis and you are tracking trends, pair Ara h 6 with Ara h 2 and total peanut IgE at a minimum. Falling Ara h 6 with rising IgG4 over months is a constructive pattern. Rising Ara h 6 IgE, new symptoms with trace exposures, or discordant component results all warrant an allergist visit before changing your management or attempting any reintroduction at home.